Business · 11/06/2015Updated: 10/17/2026 · 1 min read

FDA Announces Guidance for Early-Phase Clinical Trials of Cellular and Gene Therapy Products

The FDA has released a new guidance document to help industry sponsors and investigators design early-phase clinical trials for cellular therapy and gene therapy products, focusing on safety, tolerability, and feasibility assessments.